Evidence map›Paper›PMID 39616202›Full record

ArticleNature communications2024

Metal-organic framework membranes with scale-like structure for efficient propylene/propane separation.

Lun Shu, Yuan Peng, Chenyu Zhu, Kun Li, Weishen Yang

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lun ShuState Key Laboratory of Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, P. R. China.ORCID http://orcid.org/0009-0005-7789-8335
Yuan PengState Key Laboratory of Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, P. R. China. pengyuan@dicp.ac.cn.ORCID http://orcid.org/0000-0003-3797-0804
Chenyu ZhuState Key Laboratory of Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, P. R. China.
Kun LiState Key Laboratory of Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, P. R. China.ORCID http://orcid.org/0009-0008-0226-3169
Weishen YangState Key Laboratory of Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, P. R. China. yangws@dicp.ac.cn.ORCID http://orcid.org/0000-0001-9615-7421

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fabrication of metal-organic framework (MOF) membranes with high propylene/propane selectivity, high mechanical endurance and ease of scaling up always remains a challenge. Inspired by the ubiquitous biological wear-resistant structure, here we show ZIF-67 membranes with a tangential-normal interlaced structure (TN-ZIF-67) for one-step acquisition of polymer-grade propylene, which is endowed with the merits of intergranular defect elimination, partial ZIF-67 lattice flexibility restriction and anti-wear of the membrane surface. The TN-ZIF-67 membrane exhibits an optimal propylene/propane mixture separation factor of 221, and the separation performance remained unchanged after 1.5 years of storage or abrasion by repeated sanding. The distinctive membrane structure can be further scaled up on 4 mm-diameter tubular substrates. This work demonstrates a strategy to extend the rational design of defect-free, anti-wear MOF membranes with superior separation performance and stability that could fulfill future industrial applications.

Identifiers

PMID39616202
PMCPMC11608334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.